Downregulation of SULF1 mRNA in ovarian cancer cells, achieved via siRNA, reduces sensitivity to cisplatin-induced cytotoxicity, indicating that loss of SULF1 mRNA promotes chemoresistance. Here, SULF1 is linked to ovarian carcinoma.